Here we report a case of severe tricuspid regurgitation related to the pacemaker lead incarcerated in the chordae tendinae, resulting in significantly reduced systolic function of right ventricular and right sided heart failure. The necessity of echocardiography is ignored in the follow-ups after pacemaker implantation, which may be useful for optimal lead placement.
iNtRoductioN
Tricuspid valve (TV) dysfunction associated with cardiac implantable electronic device has gained increasing recognition as having hemodynamic and clinical consequences.
cAse RepoRt
A 69-year-old woman was referred to our hospital with progressive shortness of breath and edema of lower extremity. She had a dual-chamber pacemaker implanted 4 years prior in another clinic center due to brady-tachy-arrhythmia syndrome. The electrocardiogram at the time of referral revealed normal function of the pacemaker. Transthoracic echocardiography (TTE) demonstrated tethered tricuspid leaflets and tricuspid incompetence related to the pacemaker lead incarcerated in the chordae tendineae (bold white arrow), resulting in extremely severe tricuspid regurgitation (TR), dilated right atrium and ventricle, and significantly reduced right ventricular systolic function [ Figure 1a ]. Tricuspid annular plane systolic excursion was 9 mm. The peak pressure gradient of TR was 17 mmHg, indicating normal pulmonary artery pressure [ Figure 1b ]. The incarcerated pacemaker lead was confirmed in the three-dimensional (3D) four-chamber apical view [ Figure 1c ] as well as in the 2D right ventricular inflow view [ Figure 1d ]. Remarkably dilated inferior vena cava was also detected. Cardiothoracic surgery was consulted for lead extraction and TV replacement, but the patient was not recommended as a candidate for the surgery, due to the long course of her disease. Heart transplantation was recommended, but the patient refused.
discussioN
Apart from regurgitation, tricuspid stenosis has also been reported to develop secondary to implantation of a permanent pacemaker lead. [1] In the era of implantable device therapy, given the detrimental effect of significant TR on function and survival, any opportunity to minimize iatrogenic TR should be considered. These cases indicate the necessity of TTE in follow-ups after pacemaker implantation, which may be useful for optimal lead placement and avoiding a similar situation. Furthermore, research and development of cardiac implantable devices without a lead is in urgent need. [2] Tricuspid 
